(Q39103011)

9 September 2017

title

Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes (English)

1 reference

9 September 2017

1 reference

Ramzi Jeddi

1

1 reference

9 September 2017

Mériem Achour

2

1 reference

9 September 2017

Ramzi Ben Amor

3

1 reference

9 September 2017

Lamia Aissaoui

4

1 reference

9 September 2017

Walid Bouterâa

5

1 reference

9 September 2017

Karima Kacem

6

1 reference

9 September 2017

Raihane Ben Lakhal

7

1 reference

9 September 2017

Héla Ben Abid

8

1 reference

9 September 2017

Zaher BelHadjAli

9

1 reference

9 September 2017

Amel Turki

10

1 reference

9 September 2017

Balkis Meddeb

11

1 reference

9 September 2017

publication date

1 February 2010

1 reference

9 September 2017

1 reference

9 September 2017

volume

15

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

28-32

1 reference

Management of fever in neutropenic patients with different risks of complications

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Epidemiology of sepsis syndrome in 8 academic medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Predictive factors of septic shock and mortality in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Hypophosphatemia: clinical consequences and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Effects of albumin supplementation on microvascular permeability in septic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Myocardial dysfunction in sepsis: mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

21 January 2018

Sepsis and the heart.

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12583347009577

10.1179/102453310X12583347009577

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference